References
- Hammer, R. H. (1995). Anticoagulants, coagulants and plasma extenders. In Principles of Medicinal Chemistry, edited by W. O. Foye, T. L. Lemke, and D. A. Williams, New Delhi, India, B. I. Waverly Pvt. Ltd., pp. 388–404.
- Majerus, P. W., Broze, G. J., Jr., Miletich, J. P., and Tollefsen, D. M. (1995). Anticoagulant, thrombolytic and antiplatelet drugs. In Goodman and Gilman's The Pharmacological Basis of Therapeutics, edited by J. G. Hardman and L. E. Limbard, New York, McGraw-Hill, pp. 1341–1359.
- Smyth, R. D., Perigard, C. P., and Smyth, R. J. (1995). Clinical analysis. In Remington: The Science and Practice of Pharmacy, edited by A. R. Gennaro, Pennsylvania, Mack Publishing Co., pp. 501–533.
- Herron, D. K., Goodson, T., Jr., Wiley, M. R., Weir, L. C., Kyle, J. A., Yee, Y. K., Tebbe, A. L., Tinsley, J. M., Mendel, D., Masters, J. J., Franciskovich, J. B., Sawyer, J. S., Beight, D. W., Ratz, A. M., Milot, G., Hall, S. E., Klimkowski, V. J., Wikel, J. H., Eastwood, B. J., Towner, R. D., Gifford-Moore, D. S., Craft, T. J., and Smith, G. F. (2000). 1,2-Dibenzamidobenzene inhibitors of human factor Xa. J. Med. Chem., 43, 859–872.
- Al-Obeidi, F., and Ostrem, J. A. (1998). Factor Xa inhibitors by classical and combinatorial chemistry. Drug Discovery Today, 3, 223–231.
- Sanderson, P. E. J. (1999). Noncovalent serine protease inhibitors. Med. Res. Rev., 19, 179–197.
- Yee, Y. K., Tebbe, A. L., Linebarger, J. H., Beight, D. W., Craft, T. J., Gifford-Moore, D., Goodson, T., Jr., Herron, D. K., Klimkowski, V. J., Kyle, J. A., Sawyer, J. S., Smith, G. F., Tinsley, J. M., Towner, R. D., Weir, L., and Wiley, M. R. (2000). <I>N</I> 2-Aroylanthranilamide inhibitors of human factor Xa. J. Med. Chem., 43, 873–882.
- Franke, R. (1984). Theoretical Drug Design Methods, Amsterdam, Elsevier, pp. 184–195.
- Franke, R., and Gruska, A. (1995). Principal component and factor analysis. In Chemometric Methods in Molecular Design, Vol. II, edited by H. van de Waterbeemd, Weinheim, Germany VCH, pp. 113–163.
- Snedecor, G. W., and Cochran, W. G. (1967). Statistical Methods, New Delhi, India, Oxford & IBH Publishing Co. Pvt. Ltd., pp. 381–418.
- Kier, L. B., and Hall, L. H. (1992). Atom description in QSAR models: Development and use of an atom level index. Adv. Drug Design, 22, 1–38.
- Wold, S., and Errikson, L. (1995). Validation tools. In Chemometric Methods in Molecular Design, edited by H. van de Waterbeemd, Weinheim, Germany, VCH, pp. 309–318.
- MINITAB is a statistical software of Minitab Inc., New York.
- The GW-BASIC programs RRR98, KRPRES1 and KRPRES2 were developed by Kunal Roy (1998) and standardized on known data sets.
- Kubinyi, H. (1995). The quantitative analysis of structure activity relationships. In Burger's Medicinal Chemistry and Drug Discovery, 5th ed., Vol. I, edited by M. E. Wolff, New York, John Wiley & Son, pp. 507–509.